“Noncognitive” symptoms of early Alzheimer disease

Objectives: To observe the natural time course of noncognitive symptoms before the onset of symptomatic Alzheimer disease dementia. Methods: Using the National Alzheimer's Coordinating Center Uniform Data Set from September 2005 to March 2013, data from cognitively normal individuals who were aged 50 years or older at first visit and had subsequent follow-up were analyzed. Survival analyses were used to examine the development of particular symptoms relative to each other on the Neuropsychiatric Inventory Questionnaire (NPI-Q), Functional Activities Questionnaire, and Geriatric Depression Scale, and to compare the development of individual symptoms for persons who did and did not receive a Clinical Dementia Rating (CDR) >0 (indicating abnormal cognition) during the follow-up period. Results: The order of symptom occurrence on the NPI-Q was similar for participants who remained at CDR 0 and for those who received a CDR >0 over the follow-up period, although the time to most NPI-Q symptoms was faster for participants who received a CDR >0 (p < 0.001). With the exception of memory, Geriatric Depression Scale symptoms reported by both CDR groups were similar. Conclusions: We found a significantly earlier presence of positive symptoms on the NPI-Q in cognitively normal patients who subsequently developed CDR >0. Among participants with no depression symptoms at baseline, results suggest that depressive symptoms may increase with aging regardless of incipient dementia. Such findings begin to delineate the noncognitive course of Alzheimer disease dementia in the preclinical stages. Future research must further elucidate the correlation between noncognitive changes and distinct dementia subtypes.

[1]  J. Morris,et al.  The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[2]  J. K. Djernes,et al.  Prevalence and predictors of depression in populations of elderly: a review , 2006, Acta psychiatrica Scandinavica.

[3]  A. Fagan,et al.  CSF biomarkers of Alzheimer disease , 2013, Neurology.

[4]  D. Coakley,et al.  A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease , 2002, International journal of geriatric psychiatry.

[5]  Francesco Raudino,et al.  Non-cognitive symptoms and related conditions in the Alzheimer’s disease: a literature review , 2013, Neurological Sciences.

[6]  I. McKeith,et al.  Prevalence, correlates and course of behavioural and psychological symptoms of dementia in the population , 2009, British Journal of Psychiatry.

[7]  K. Blennow,et al.  The relationship between cerebrospinal fluid biomarkers and depression in elderly women. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[8]  J. Morris,et al.  The Uniform Data Set (UDS): Clinical and Cognitive Variables and Descriptive Data From Alzheimer Disease Centers , 2006, Alzheimer disease and associated disorders.

[9]  W. Kamphorst,et al.  Relation between neuritic plaques and depressive state in Alzheimer's disease , 2010, Acta Neuropsychiatrica.

[10]  L. Tan,et al.  Behavioral and Psychological Symptoms in Alzheimer's Disease , 2014, BioMed research international.

[11]  S. Hui,et al.  The relationship between non‐cognitive symptoms and functional impairment in Alzheimer's disease , 2004, International journal of geriatric psychiatry.

[12]  Michael A Rapp,et al.  Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression. , 2006, Archives of general psychiatry.

[13]  J. Morris The Clinical Dementia Rating (CDR) , 1993, Neurology.

[14]  K. Blennow,et al.  Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. , 2012, The American journal of psychiatry.

[15]  T. Kurosaki,et al.  Measurement of functional activities in older adults in the community. , 1982, Journal of gerontology.

[16]  D. Perl,et al.  Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[17]  J. Cummings,et al.  Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. , 2000, The Journal of neuropsychiatry and clinical neurosciences.

[18]  Nathaniel Mercaldo,et al.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery , 2009, Alzheimer disease and associated disorders.

[19]  R. Penn,et al.  Stiff‐man syndrome treated with intrathecal baclofen , 1993, Neurology.

[20]  P. Deyn,et al.  Neuropsychological and behavioural correlates of CSF biomarkers in dementia , 2006, Neurochemistry International.

[21]  D. Mograbi,et al.  Anosognosia, autobiographical memory and self knowledge in Alzheimer's disease , 2013, Cortex.

[22]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .